US Patent Issued to Yuhan on June 3 for "Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt" (South Korean Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,390, issued on June 3, was assigned to Yuhan Corp. (Seoul, South Korea).

"Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt" was invented by Seongkyu Kim (Seoul, South Korea), Deokkyu Lee (Seoul, South Korea), Soo-Won Kim (Gyeonggi-do, South Korea), Jun-Mo Yang (Gyeonggi-do, South Korea) and Yoong-Sik Park (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a pharmaceutical composition for oral administration comprising: N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pirimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide (Lazertinib) ...